Skip to content

Melissa Catherine Mizesko, M.D.

NPI 1003026139ActiveIndividual· Pediatrics, Pediatric Rheumatology· Corpus Christi, TX

Pediatrics, Pediatric Rheumatology (M.D.) in Corpus Christi, Texas, licensed in TX, with an NPI issued in May 2007. Part D covered 21 prescriptions written in 2024, 52% of them generic. Glaxosmithkline, LLC. reported $119.35 in payments in 2025, mostly food and beverage.

Overview

NPI1003026139
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedMay 24, 2007
Last updated in NPPESDec 4, 2020
Certified by providerDec 4, 2020

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Rheumatology Primary2080P0216XP7814TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Rheumatology (TX)

Part D prescriptions in 2024

Prescriptions (claims)21 · 21 30-day fills
Total drug cost$85,491
Generic share52% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$119.35 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Glaxosmithkline, LLC.$119.351

What the 2025 payments were for

  • Food and Beverage$119.35 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records